EZZ Life Science Holdings Ltd
ASX:EZZ
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
Bank of America Corp
NYSE:BAC
|
US |
|
Mastercard Inc
NYSE:MA
|
US |
|
UnitedHealth Group Inc
NYSE:UNH
|
US |
|
Exxon Mobil Corp
NYSE:XOM
|
US |
|
Pfizer Inc
NYSE:PFE
|
US |
|
Nike Inc
NYSE:NKE
|
US |
|
Visa Inc
NYSE:V
|
US |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
Coca-Cola Co
NYSE:KO
|
US |
|
Verizon Communications Inc
NYSE:VZ
|
US |
|
Chevron Corp
NYSE:CVX
|
US |
|
Walt Disney Co
NYSE:DIS
|
US |
|
PayPal Holdings Inc
NASDAQ:PYPL
|
US |
EZZ Life Science Holdings Ltd
Accounts Payable
EZZ Life Science Holdings Ltd
Accounts Payable Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Accounts Payable | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
E
|
EZZ Life Science Holdings Ltd
ASX:EZZ
|
Accounts Payable
AU$3.5m
|
CAGR 3-Years
13%
|
CAGR 5-Years
2%
|
CAGR 10-Years
N/A
|
|
|
Genetic Technologies Ltd
ASX:GTG
|
Accounts Payable
AU$2.6m
|
CAGR 3-Years
22%
|
CAGR 5-Years
29%
|
CAGR 10-Years
10%
|
|
|
Anteotech Ltd
ASX:ADO
|
Accounts Payable
AU$219.2k
|
CAGR 3-Years
-42%
|
CAGR 5-Years
-11%
|
CAGR 10-Years
-12%
|
|
|
Proteomics International Laboratories Ltd
ASX:PIQ
|
Accounts Payable
AU$471.9k
|
CAGR 3-Years
87%
|
CAGR 5-Years
34%
|
CAGR 10-Years
N/A
|
|
|
T
|
Trajan Group Holdings Ltd
ASX:TRJ
|
Accounts Payable
AU$11.1m
|
CAGR 3-Years
9%
|
CAGR 5-Years
40%
|
CAGR 10-Years
N/A
|
|
|
Cryosite Ltd
ASX:CTE
|
Accounts Payable
AU$1.7m
|
CAGR 3-Years
29%
|
CAGR 5-Years
17%
|
CAGR 10-Years
5%
|
|
EZZ Life Science Holdings Ltd
Glance View
EZZ Life Science Holdings Ltd. engages in wholesale distributor of skin care products under the EAORON brand to pharmacies, supermarkets and specialist retailers. The company is headquartered in Sydney, New South Wales. The company went IPO on 2021-03-03. The firm is wholesale distributor of EAORON skin care products for the Australian and New Zealand markets. The company develops, manufactures and distributes genetic technology enabled consumer health products under its own brand, EZZ. The EAORON brand comprises of five product lines, including Hyaluronic Series, Facial Mask Series, Crystal White Series, Specific Care Series and Anti-Sugar Series. The EZZ products cover market segments, including vitamin and dietary supplements, sports nutrition, wright management and wellbeing, herbal/ traditional and pediatric consumer health products.
See Also
What is EZZ Life Science Holdings Ltd's Accounts Payable?
Accounts Payable
3.5m
AUD
Based on the financial report for Jun 30, 2025, EZZ Life Science Holdings Ltd's Accounts Payable amounts to 3.5m AUD.
What is EZZ Life Science Holdings Ltd's Accounts Payable growth rate?
Accounts Payable CAGR 5Y
2%
Over the last year, the Accounts Payable growth was 26%. The average annual Accounts Payable growth rates for EZZ Life Science Holdings Ltd have been 13% over the past three years , 2% over the past five years .
